Delivery Order SPE2DB22D1041-SPE2DB25FTZK6
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,789.20 firm fixed-price delivery order is for the supply of amlodipine-valsartan 5-160 mg tablets. The contract has an ultimate completion date of November 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,066.13 firm fixed-price contract is for the supply of valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,153.56 firm-fixed-price contract is for the supply of valsartan-HCTZ 320-25 mg tablets, a cardiovascular medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Amlodipine-Valsartan 5-160 mg 30s medication. The $12,960.31 contract has a performance period through March 7, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
This award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The $4,965.21 firm fixed-price contract has an ultimate completion date of August 1, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and Department of Justice worth up to $999,999,999 and $750,000, respectively, for providing a diverse range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,424.65, is for the delivery of Valsartan-HCTZ 320-25 mg tablets over a two-year period ending in November 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,291.34 firm fixed-price delivery order is for the supply of AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication, with a period of performance ending on November 1, 2024. This award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,151.96, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. This is a Firm Fixed Price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical to the pharmaceutical distributor Amerisourcebergen Drug Corporation. The $2,446.67 fixed-price contract is for the supply of Valsartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of July 19, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,172.84 firm fixed-price contract is for the provision of the pharmaceutical product "AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S" with a period of performance through May 21, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, including the Department of Defense and Veterans Affairs....